European Journal of Molecular & Clinical Medicine

Abstract

This project covers the entire scenario of how likely were the investments in pharma companies during the time period of lockdown due to the outburst of COVID-19. It covers an entire research, it’s results, conclusions and all the analysis based on the investment in pharma companies. Ultimate aim was to analyze the impact of the COVID-19 scenario. The regular goal of the business, society and the public authorities, was to guarantee congruity in the inventory of basic, life-saving meds that are fundamental for limiting medical issues during the pandemic.